Back to search
FDAFDA · Food and drugs·Recall number Z-2736-2014

Verigene BC-GN Kit (Catalog number 20-005-021); 1) 20 Verigene BC-GN Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for simultaneous detection and identification of selected gram-positive (BC-GP) and gram-negative (BC-GN) bacteria and resistance markers.

Published October 8, 2014 · Recall initiated: June 17, 2013

Summary

FDA records medical device Class II recall Z-2736-2014, published October 8, 2014 and initiated June 17, 2013. Recalling firm: Nanosphere, Inc.; Status: Terminated; Reported quantity: 20 extraction trays; Lot: Part Number: 20-009-021; Lot Numbers: 052113021C. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Nanosphere, Inc.
Distributor
Worldwide Distribution:US (Nationwide) including states of: AZ, CA, FL, IL, KY, MD, MN, MT, OH, PA, TN, TX, VA, WA, WI; and countries of: Belgium, China, and Saudi Arabia.
Lot
Part Number: 20-009-021; Lot Numbers: 052113021C
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Verigene BC-GN Kit (Catalog number 20-005-021); 1) 20 Verigene BC-GN Test Cartridges; are qualitative multiplexed in vitro diagnostic tests for simultaneous detection and identification of selected gram-positive (BC-GP) and gram-negative (BC-GN) bacteria and resistance markers. recalled?

Yes. FDA published recall Z-2736-2014 on October 8, 2014. Reported hazard: There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail